Presented ByDr Riccardo Lencioni, University of Pisa, Italy
TrialPhase 3, EMERALD-1 ConferenceASCO GI 2024
13 February, 2024 12:57
Presented ByDr Julian Holch, Ludwig-Maximilians-University of Munich, Germany
TrialPhase 3, FIRE-3 (AIO KRK0306) ConferenceASCO GI 2024
13 February, 2024 12:31
Presented ByDr Meredith Pelster, Sarah Cannon Research Institute, TN, USA
TrialPhase 2, DeFianCe ConferenceASCO GI 2024
13 February, 2024 12:10
Presented ByDr Philipp Harter, Kliniken Essen-Mitte, Germany
TrialPhase 3, DUO-O ConferenceASCO 2023
1 August, 2023 12:44
Presented ByProf. Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, CA, USA
TrialPhase 2, IMbrave151 ConferenceASCO GI 2023
17 March, 2023 09:15
Presented ByDr Kohei Shitara, National Cancer Center Hospital East, Japan
TrialPhase 3, PARADIGM ConferenceASCO GI 2023
17 March, 2023 09:01
Presented ByProf. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain
TrialPhase 3, SUNLIGHT ConferenceASCO GI 2023
17 March, 2023 08:45
Presented ByDr Takayuki Yoshino, National Cancer Center Hospital East, Japan
TrialPhase 3, PARADIGM ConferenceASCO 2022
5 August, 2022 15:19
Presented ByProf. Cornelis Punt, University Medical Center Utrecht, the Netherlands
TrialPhase 3, CAIRO5 ConferenceASCO 2022
5 August, 2022 15:11
Presented ByDr Robert van den Heuvel, Medicom
ConferenceASCO 2022
21 June, 2022 09:38
Presented ByDr Hyeyeong Kim, Ulsan University Hospital, South Korea
TrialPhase 3, IMbrave150 ConferenceASCO GI 2022
21 March, 2022 10:00
Presented ByDr Filippo Pietrantonio, Istituto Nazionale dei Tumori di Milano, Italy & Dr Chiara Cremolini, Azienda Ospedaliero-Universitaria Pisana, Italy
TrialPhase 2, MAYA & AtezoTRIBE ConferenceESMO 2021
19 November, 2021 09:42
Presented ByProf. Nicoletta Colombo, Istituto Europeo di Oncologia, Italy
TrialPhase 3, KEYNOTE-826 ConferenceESMO 2021
19 November, 2021 09:23
Presented ByDr Samantha Dean, Austin Health, Australia
TrialPhase 3, IMpower150 ConferenceWCLC 2021
21 September, 2021 13:23
Presented ByProf. David O’Malley, Ohio State University, OH, USA
TrialPhase 1/2, FORWARD II ConferenceASCO 2021
12 August, 2021 22:43
Presented ByProf. Richard Finn, UCLA, USA
TrialPhase 3, IMbrave150 ConferenceASCO GI 2021
12 March, 2021 11:39
Presented ByProf. Thomas Seufferlein, University of Ulm, Germany
TrialPhase 1/2, PERMAD ConferenceASCO GI 2021
12 March, 2021 11:37
Presented ByProf. Eric Van Cutsem, KU Leuven, Belgium
TrialPhase 2, TASCO1 ConferenceASCO GI 2021
12 March, 2021 11:35
ConferenceESMO 2020
25 November, 2020 14:58
ConferenceESMO 2020
25 November, 2020 14:39
Presented ByProf. Yohann Loriot, Université Paris-Saclay, France
TrialBLC2001; THOR; EV-301; EV-302; TROPHY-U-01; RANGE ConferenceEAU 2020
20 August, 2020 12:36
Presented ByProf. Isabelle Ray-Coquard, Université Claude Bernard, Lyon, France
TrialPhase 3, PAOLA-1/ENGOT-ov25 ConferenceESMO 2019
26 November, 2019 23:25
TrialPhase 2, BEACON-Neuroblastoma ConferenceESMO 2019
26 November, 2019 14:29
Presented ByDr Javier Sastre, Hospital Clínico San Carlos, Spain
TrialPhase 3, VISNU-1 ConferenceASCO 2019
15 July, 2019 23:53
Presented ByProf. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland
TrialIMpower 150 ConferenceELCC 2019
25 June, 2019 21:17
Presented ByProf. Martin Reck, German Center for Lung Research, Germany
ConferenceWCLC 2018
21 November, 2018 22:05
